{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:58:22Z","timestamp":1787979502743,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSH234200637015C"],"award-info":[{"award-number":["HHSH234200637015C"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24-CA76518"],"award-info":[{"award-number":["U24-CA76518"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSH234200637015C"],"award-info":[{"award-number":["HHSH234200637015C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.eclinm.2024.102819","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T05:15:01Z","timestamp":1725513301000},"page":"102819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-4243","authenticated-orcid":false,"given":"Mary","family":"Eapen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell E.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqun","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary M.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Joachim","family":"Deeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2024.102819_bib1","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia","volume":"129","author":"Bacigalupo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2024.102819_bib2","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia","volume":"376","author":"Townsley","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2024.102819_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.2021012130","article-title":"Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study","volume":"139","author":"Patel","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2024.102819_bib4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1182\/blood-2006-03-005041","article-title":"Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy","volume":"108","author":"Deeg","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2024.102819_bib5","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3324\/haematol.2009.018267","article-title":"Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anaemia: a retrospective study from the EBMT-SAA working party","volume":"95","author":"Bacigalupo","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.eclinm.2024.102819_bib6","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2011-05-354001","article-title":"Effect of stem cell source on outcomes after adult unrelated donor transplantation in severe aplastic anemia","volume":"118","author":"Eapen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2024.102819_bib7","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1016\/S2352-3026(15)00147-7","article-title":"Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study","volume":"2","author":"Anderlini","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.eclinm.2024.102819_bib8","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bbmt.2012.04.014","article-title":"Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose de-escalation study show life-threatening adverse events at predefined cyclophosphamide dose levels","volume":"18","author":"Tolar","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.eclinm.2024.102819_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/bmt.2012.239","article-title":"Graft failure in the modern era of allogeneic hematopoietic SCT","volume":"48","author":"Olsson","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.eclinm.2024.102819_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft versus host disease: the 2014 diagnosis and staging working group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.eclinm.2024.102819_bib11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/(SICI)1097-0258(19970430)16:8<901::AID-SIM543>3.0.CO;2-M","article-title":"Non-parametric inference for cumulative functions in competing risk studies","volume":"16","author":"Lin","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.eclinm.2024.102819_bib12","series-title":"Survival analysis: techniques of censored and truncated data","author":"Klein","year":"2003"},{"key":"10.1016\/j.eclinm.2024.102819_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.0006-341X.2004.00218.x","article-title":"Dose-finding based on efficacy-toxicity trade-offs","volume":"60","author":"Thall","year":"2004","journal-title":"Biometrics"},{"key":"10.1016\/j.eclinm.2024.102819_bib14","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.eclinm.2024.102819_bib15","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1182\/blood-2014-05-526285","article-title":"Bone marrow failure and telemeropathies","volume":"124","author":"Townsley","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2024.102819_bib16","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3324\/haematol.2017.169862","article-title":"Incidence and outcome of acquired aplastic anemia: real-world data from patient diagnosis in Sweden","volume":"102","author":"Vaht","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102819_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1182\/asheducation-2018.1.467","article-title":"Alternative donor transplants for severe aplastic anemia","volume":"2018","author":"Bacigalupo","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.eclinm.2024.102819_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbmt.2018.08.029","article-title":"Allogeneic hematopoietic cell transplantation in patients aged 50 years or older with severe aplastic anemia","volume":"25","author":"Rice","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.eclinm.2024.102819_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood-2018-09-876284","article-title":"The hematopoietic cell transplant comorbidity index predicts survival after allogeneic transplant for non-malignant diseases","volume":"133","author":"Thakar","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2024.102819_bib20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bbmt.2012.06.018","article-title":"Late effects in hematopoietic cell transplant recipients with acquired severe aplastic anemia: a report from the late effects working committee of the center for international blood and marrow transplant research","volume":"18","author":"Buchbinder","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.eclinm.2024.102819_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1056\/NEJM199907013410103","article-title":"Long term survival and late deaths after allogeneic bone marrow transplantation","volume":"341","author":"Socie","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eclinm.2024.102819_bib22","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1200\/JCO.2010.33.7212","article-title":"Long-term survival and late deaths after allogeneic hematopoietic cell transplantation","volume":"29","author":"Wingard","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.eclinm.2024.102819_bib23","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1016\/S2352-3026(22)00206-X","article-title":"Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single arm, phase 2 trial","volume":"9","author":"DeZern","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.eclinm.2024.102819_bib24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3324\/haematol.2014.115345","article-title":"Aplastic anemia working party of the european group for blood and marrow transplantation. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis","volume":"100","author":"Bacigalupo","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.eclinm.2024.102819_bib25","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/bloodadvances.2020001729","article-title":"Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide","volume":"4","author":"DeZern","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.eclinm.2024.102819_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancies","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.eclinm.2024.102819_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024003985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024003985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:08:45Z","timestamp":1732061325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024003985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":27,"alternative-id":["S2589537024003985"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102819","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102819"}}